Prognostic Factors in Hodgkin Lymphoma

Hodgkin lymphoma (HL) is among the neoplastic diseases that has the best long-term outcome after cytotoxic treatment. Cure rates approach 80–90%; however, 15–20% of patients will be resistant to therapy (primary refractory) or relapse after treatment. Prognostic factors should help to stratify treat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cuccaro, Annarosa, Bartolomei, Francesca, Cupelli, Elisa, Galli, Eugenio, Giachelia, Manuela, Hohaus, Stefan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Università Cattolica del Sacro Cuore 2014
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103502/
https://ncbi.nlm.nih.gov/pubmed/25045461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.053
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller